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DOI 10.1016/j.ccr.2009.12.041SUMMARYCancer-associated fibroblasts (CAFs) support tumorigenesis by stimulating angiogenesis, cancer cell prolif-
eration, and invasion. We demonstrate that CAFs also mediate tumor-enhancing inflammation. Using
a mouse model of squamous skin carcinogenesis, we found a proinflammatory gene signature in CAFs
isolated from dysplastic skin. This signature was maintained in CAFs from subsequent skin carcinomas
and was evident in mammary and pancreatic tumors in mice and in cognate human cancers. The inflamma-
tory signature was already activated in CAFs isolated from the initial hyperplastic stage in multistep skin
tumorigenesis. CAFs from this pathway promoted macrophage recruitment, neovascularization, and tumor
growth, activities that are abolished when NF-kB signaling was inhibited. Additionally, we show that normal
dermal fibroblasts can be ‘‘educated’’ by carcinoma cells to express proinflammatory genes.INTRODUCTION
Although tumorigenesis has classically been viewed as a largely
cell-autonomous process involving genetically transformed
cancer cells, the importance of stromal cell types populating
the neoplastic microenvironment is nowwell accepted (reviewed
in Bissell and Radisky, 2001; Hanahan andWeinberg, 2000; Tlsty
and Coussens, 2006). Studies investigating the link between
inflammation and cancer have been particularly revealing,
demonstrating that inflammatory immune cells are recruited to
neoplasias, where they in many cases markedly promote tumor
progression by facilitating multiple hallmark capabilities (de
Visser et al., 2006; Karin and Greten, 2005; Mantovani et al.,
2008). Immune cells have been documented to supply soluble
growth and survival factors, matrix remodeling enzymes,
reactive oxygen species, and other bioactive molecules thatSignificance
Chronic inflammation is highly correlated with many types
fibroblasts (CAFs) express a proinflammatory gene signature
CAFs from a transgenic mouse model of squamous cell carcin
tumor growth. Inhibition of NF-kB signaling abolished these tu
for tumor-enhancing inflammation mediated by CAFs. These
tumorigenesis, but also have important implications for therape
ing that inhibiting stromal NF-kB signaling could be of value in
Cvariously influence cancer cell proliferation, angiogenesis, inva-
sion, and metastasis (De Marzo et al., 1999; Kuper et al., 2000;
van Kempen et al., 2006).
A second stromal component of importance for tumorigenesis
is cancer-associated fibroblasts (CAFs). CAFs are phenotypi-
cally and functionally distinguishable from their normal counter-
parts in their increased rate of proliferation and differential
expression of extracellular matrix (ECM) components and
growth factors (Bhowmick et al., 2004b; Kalluri and Zeisberg,
2006). Several studies have demonstrated that normal fibro-
blasts have a role in maintaining epithelial homeostasis by sup-
pressing proliferation and oncogenic potential of adjacent
epithelia (Begley et al., 2008; Bhowmick et al., 2004a; Trimboli
et al., 2009). However, following neoplastic transformation of
epithelia, CAFs have been shown to promote tumor growth
by inducing angiogenesis, recruiting bone marrow–derivedof human cancer. Here we show that cancer-associated
in skin, breast, and pancreatic cancers. Proinflammatory
oma mediated immune cell recruitment, angiogenesis, and
mor-promoting effects, demonstrating that NF-kB is critical
results not only demonstrate a role for CAFs in promoting
utic targeting of CAF regulatory or effector circuits, suggest-
treating certain forms of human cancer.
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Figure 1. PDGFRa is Broadly Expressed
in Normal and Neoplastic Skin Fibroblasts
(A) H&E staining of skin from nontransgenic
control ears (left), a 4-month-old HPV16 mouse
with dysplasia (middle), or a squamous cell carci-
noma (SCC) (right).
(B) PDGFRa expression is restricted to the stromal
compartment in skin and tumors. Immunohisto-
chemical analysis of PDGFRa (Rhodamine-X,
red) in the same tissue as in (A). E, epithelium; S,
stroma. DAPI staining is shown in blue. The panels
are representative of multiple fields of skin
sections from two control and four HPV mice.
(C) Immunofluorescent staining of cultured fibro-
blasts sorted from dysplastic ear. All fibroblasts
express PDGFRa (FITC). Only a subset of
PDGFRa+ fibroblasts expresses a-SMA (FITC).
Scale bar, 100 mM. See also Figure S1.
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Cancer-Associated Fibroblasts mediate inflammationendothelial progenitor cells, and remodeling the ECM (Allinen
et al., 2004; Olumi et al., 1999; Orimo et al., 2005; Pietras
et al., 2008). Interestingly, CAFs can even mediate resistance
to antiangiogenic therapy (Crawford et al., 2009). It is increas-
ingly apparent that CAFs are a diverse cell population that can
have different characteristics in different tumor types and tissue
locales. Some CAFs are related to myofibroblasts, an activated
form of fibroblast that plays an important role in wound healing
and is characterized by expression of a-SMA. Not all CAFs,
however, express a-SMA. Increasingly, fibroblasts in tumor
tissues are being recognized as a diverse population of myofi-
broblastic cells intermixed with other fibroblastic cells that do
not express a-SMA but may be tumor promoting nevertheless
(Desmouliere et al., 2004; Micke and Ostman, 2004; Sugimoto
et al., 2006).
To better understand the characteristics and functions of
CAFs, we set out to investigate CAFs in the K14-HPV16 mouse
model of multistep squamous skin carcinogenesis. This model
displays premalignant and malignant stages that are stereotyp-
ical of carcinogenesis in humans. K14-HPV16 transgenic mice
have proven useful for investigating multiple aspects of carcino-
genesis, including tumor-stroma interactions (Arbeit et al., 1994;
Coussens et al., 1996). These mice express the HPV16 early-
region that includes the E6/E7 oncogenes, under the control of
the human keratin-14 promoter/enhancer. Animals develop
hyperplastic and then dysplastic lesions that progress to inva-
sive squamous cell carcinomas, typically within the epidermis
of the ear or on the chest and truncal skin; by 4 months of age,
100% of transgenic animals have hyperplastic/dysplastic
lesions on their ears. The preneoplastic stage is characterized
by extensive remodeling of the underlying dermal stroma, which
facilitates both angiogenesis and eventual tumor cell invasion.
This extensive stromal remodeling develops early at the136 Cancer Cell 17, 135–147, February 17, 2010 ª2010 Elsevier Inc.dysplastic stage in all animals, well
before malignant conversion, and is
characterized by a chronic inflammatory
response.
In this study, we performed expression
profiling of fibroblasts from dysplastic
skin of K14-HPV16 transgenic mice andinvestigated the functional implications of tumor-promoting
inflammation mediated by CAFs. Furthermore, we studied the
molecular mechanism underlying activation of naive, stromal
fibroblasts into proinflammatory, tumor-promoting CAFs begin-
ning at the earliest stages of multistep skin tumorigenesis.
RESULTS
Fibroblasts from Skin Dysplasias are Proinflammatory
Stromal changes in neoplastic skin of K14-HPV16 (HPV) mice
precede progression to invasive carcinomas. By 4 months of
age, at sites where skin tissue is focally dysplastic, the dermis
is transformed into a reactive stroma, composed of blood and
lymphatic vessels, inflammatory cells, and fibroblasts, which
persists during neoplastic progression to cancer (Coussens
et al., 1999) (Figure 1A). We sought to identify genes whose
expression changed in CAFs in early neoplastic skin lesions
compared to their normal dermal counterparts. We chose to
purify fibroblasts from normal and neoplastic tissues by FACS.
Although the myofibroblast marker a-SMA is commonly used
to identify CAFs, it is intracellular, and it is not certain that all
CAFs are a-SMA positive (Sugimoto et al., 2006). We surveyed
a number of surface markers for robust expression in skin fibro-
blasts and found PDGFRa to be the best (see Figure S1A avail-
able online). PDGFRa, which is reportedly expressed by up to
90% of stromal fibroblasts in solid tumors (Micke and Ostman,
2004), was found by immunostaining to be expressed exclu-
sively in the stromal compartments of normal skin, dysplastic
HPV tissue, andHPV skin tumors (Figure 1B). The purity of sorted
PDGFRa+ cells was verified by expression of fibroblast-specific
genes and by a lack of expression of immune cell markers (Fig-
ure S1B). When a-SMA expression was assessed in sorted skin
fibroblasts, we observed that only a subset of PDGFRa+
Table 1. Summary of Microarray Results of Proinflammatory Genes
Gene Name Gene Symbol Affymetrix Probe IDa Fold Changeb p
Chemokine (C-X-C motif) ligand 2 CXCL2 1449984_at 225.985 0.00085
Interleukin 6 IL-6 1450297_at 54.449 0.00085
Interleukin 1 beta IL-1b 1449399_a_at 47.236 0.03878
Chemokine (C-X-C motif) ligand 1 CXCL1 1457644_s_at 37.353 0.00085
Chemokine (C-X-C motif) ligand 5 CXCL5 1419728_at 37.709 0.02520
Cyclooxygenase 2 Cox-2 1417262_at 18.521 0.03465
Serglycine SRGN 1417426_at 16.612 0.02520
Chemokine (C-C motif) ligand 3 CCL3 1419561_at 15.162 0.03878
Matrix metallopeptidase 12 MMP12 1449153_at 11.502 0.04352
Interleukin 1 family, member 9 IL-1F9 1425958_at 6.867 0.04200
Matrix metallopeptidase 3 MMP3 1418945_at 3.663 0.04515
Fibrinogen, a polypeptide FGA 1424279_at 6.942 0.03864
Nuclear receptor subfamily 4, member 1 Nur77/NR4A 1416505_at 7.920 0.04673
Secretory leukocyte peptidase inhibitor Slpi 1448377_at 8.996 0.04869
Osteopontin (secreted Phosphoprotein 1) OPN/Spp1 1449254_at 9.364 0.19182
aAffymetrix probe ID corresponds to the Mouse Genome 430 2.0 Array.
b Fold change represents HPV-16 CAFs from dysplastic skin tissue as compared to age-matched nontransgenic controls.
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Cancer-Associated Fibroblasts mediate inflammationfibroblasts expressed a-SMA (Figure 1C), indicating that we
were indeed including a larger and more heterogeneous popula-
tion of CAFs in our survey than just myofibroblasts.
We expression profiled fibroblasts sorted from dysplastic skin
tissue of K14-HPV16mice and fromage-matched controls, using
PDGFRa as a cell surface marker. Comparison of the transcrip-
tome of CAFs from dysplastic tissue to normal dermal fibroblasts
(NDFs) using the genMAPP pathway profiling software impli-
cated ‘‘inflammatory response’’ and ‘‘immune cell chemotaxis’’
pathways. We chose to focus on the most highly upregulated
genes from these pathways (Table 1). Because we have previ-
ously shown that CAFs are proangiogenic in the related HPV16
mouse model of cervical cancer (Pietras et al., 2008), we also
analyzed the microarray results for proangiogenic genes. The
expression of a number of known proangiogenic genes (e.g.,
VEGF, FGF-2, and FGF-7) was not significantly changed in
dermal CAFs, comparedwith controls (data not shown). Interest-
ingly, however, one proangiogenic gene, CYR61 (Brigstock,
2002; Monnier et al., 2008), was upregulated in dermal CAFs.
For further analysis, we selected a set of highly upregulated
‘‘signature’’ genes (Figure 2F). This predominantly proinflamma-
tory gene signature consists of two chemokines that are chemo-
attractants for neutrophils and macrophages (CXCL1, and
CXCL2); the proinflammatory cytokines IL-1b and IL-6, the latter
of which recently was implicated in the link between inflamma-
tion and cancer (Bollrath et al., 2009; Grivennikov et al., 2009);
the proangiogenic gene CYR61; COX-2, which is widely upregu-
lated in cancer and has been functionally implicated in mediating
inflammatory responses via prostaglandin production (Harris,
2009; Sahin et al., 2009); and osteopontin (OPN), which is known
to affect inflammation, angiogenesis, and metastasis (Cook
et al., 2005). Interestingly, OPN was recently implicated in tumor
enhancement by fibroblasts (Anderberg et al., 2009; Pazolli et al.,
2009). Expression of the signature genes identified from the
microarray data was validated by quantitative RT-PCR analysis
of fibroblasts sorted from dysplastic skin tissue, comparedCwith NDFs (Figure 2A). Notably, CAFs sorted from end-stage
squamous cell carcinomas in this multistep pathway continue
to express the proinflammatory gene signature identified in
premalignant dysplasias (data not shown).
CAFs in Mouse Pancreatic Ductal Adenocarcinoma
and Mammary Tumors, but Not Cervical Tumors
Are Proinflammatory
We next sought to assess the generality of the proinflammatory
gene signature in CAFs associated with other tumor types. We
therefore analyzed expression of the inflammatory signature
genes in CAFs sorted from mouse cervical, mammary, and
pancreatic tumors. The HPV16 transgenic mouse model gives
rise to cervical cancer in female mice treated with estrogen
(Arbeit et al., 1996; Elson et al., 2000). Cervical carcinogenesis
in this model is also characterized by recruitment of proangio-
genic macrophages and the induction and persistence of angio-
genesis (Giraudo et al., 2004). Despite their similarities in tumor
type and initiating oncogenes, fibroblasts sorted from cervical
dysplasias (Figure 2B) and cervical tumors (data not shown),
unlike dermal HPV CAFs, did not express the inflammatory
gene signature, suggesting that other cell types orchestrate
the inflammatory response in this pathway. The proangiogenic
gene CYR61 was, however, highly expressed by cervical CAFs
and thus may participate in CAF-mediated angiogenic stimula-
tion in this model.
Breast tumors and pancreatic ductal adenocarcinomas
(PDACs) are both characterized by an extensive desmoplastic
stroma, abundantly populated by fibroblasts (Korc, 2007; Maha-
devan and Von Hoff, 2007; Walker, 2001). We assessed the
CAFs from mammary adenocarcinomas in the MMTV-PyMT
transgenic mousemodel (Guy et al., 1992; Lin et al., 2003). Fibro-
blasts sorted from mammary tumors of 3-month-old mice
expressed components of the inflammatory signature, whereas
normal mammary fibroblasts did not (Figure 2C). CAFs sorted
from PDACs of p48-Cre, LSL-KrasG12D, p53fl/+ mice (Bardeesyancer Cell 17, 135–147, February 17, 2010 ª2010 Elsevier Inc. 137
Figure 2. Expression of a Proinflammatory
Gene Signature by CAFs in Skin, Cervical,
Mammary, and Pancreatic Tumors
(A) qRT-PCR of PDGFRa+ fibroblasts FACS
sorted from ear tissue of 4-month-old HPV mice
or normal dermal fibroblasts (NDFs) sorted from
nontransgenic control mice. Fibroblasts were
sorted from a pool of tissue from 15 age-matched
mice. Results are representative of at least three
independent experiments. Pound sign (#) indi-
cates undetectable/very low expression.
(B) CAFs were FACS sorted from 3-month-old
estrogen-treated female HPV mouse cervixes or
from dysplasias on the ears of 4-month-old HPV
mice. Results shown are from pools of tissue
from 10 age-matched mice. Normal cervical fibro-
blasts were unavailable for comparison because
of the difficulty of obtaining a sufficient amount
of sorted fibroblasts from normal mouse cervixes.
ND, not done.
(C) CAFs were sorted from two MMTV-PyMT
tumors compared to normal fibroblasts from the
mammary glands of six age-matched nontrans-
genic control mice.
(D) CAFs were sorted from two pooled PDAC
tumors compared to pooled normal fibroblasts
sorted from the pancreas of eight age-matched
normal controls. All experiments were repeated
at least twice.
(E) CAFs were sorted from freshly resected human
SCC tumors or normal human skin. Results shown
are representative of two different tumors and two
normal skin samples.
(F) List of genes included in the inflammatory gene
signature. See also Figure S2.
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Cancer-Associated Fibroblasts mediate inflammationet al., 2006) were also found to express proinflammatory genes,
whereas normalmousepancreatic fibroblasts did not (Figure 2D).
These results suggest that proinflammatory signaling by CAFs is
operative in certain other tumor types.
CAFs in Human Squamous Cell Carcinoma
and PDAC Are Proinflammatory
To investigate whether this proinflammatory signature is ex-
pressed in human cancer CAFs, we analyzed the expression of
the signature genes in fibroblasts sorted from freshly resected
human SCC or PDAC tumors. Notably, CAFs sorted from human
SCC tumors expressed genes of the inflammatory signature,
whereas normal human skin fibroblasts did not (Figure 2E).
Similarly, although normal pancreatic fibroblasts were unavail-
able for comparison, the CAFs sorted from human PDAC tumors
expressed genes of the inflammatory signature (Figure S2). To
further assess the relevance of the inflammatory signature to
human cancer, we surveyed expression data from multiple
human SCC, breast, and pancreatic tumors available via the
Oncomine database (Rhodes et al., 2004). The available data
are of total tumor tissue, and not specifically of CAFs, but may
be predictive nevertheless, because the stromal component is
prominent in these tumor types. Strikingly, we found that all
the signature genes are strongly upregulated across multiple
SCC studies. Most of the genes are also upregulated in human
breast and pancreatic cancer (Figure S3).138 Cancer Cell 17, 135–147, February 17, 2010 ª2010 Elsevier Inc.Buoyed by these associations with other mouse and human
tumor types, we sought to functionally investigate the inflamma-
tory signature in skin CAFs of the mouse squamous carcinogen-
esis pathway.
Inflammatory Fibroblasts Enhance Tumor Growth,
Vascularization, and Macrophage Recruitment
To assess CAF functions, we adopted a well-established
bioassay, involving coinoculation with transformed epithelial
cells into an orthotopic site, where the effects of the fibroblasts
on tumor growth could be assessed (Olumi et al., 1999; Orimo
et al., 2005). Importantly, fibroblasts derived from HPV dys-
plastic skin maintained expression of the inflammatory gene
signature in culture (Figure S4). PDSC5 cells, an HPV16-derived
skin carcinoma cell line, were injected intradermally into FVB/n
mice either alone, admixed with HPV dysplastic skin fibroblasts
(i.e., CAFs), or admixed with fibroblasts derived from control
mice (i.e., NDFs). Tumors coinjected with CAFs grew signifi-
cantly faster and were larger than tumors in mice injected with
PDSC5 cells alone (Figure 3A). Interestingly, the tumors in mice
coinjected with NDFs had an intermediate phenotype.
We hypothesized that HPV CAFs might support tumor growth
in part through the stimulation of angiogenesis, either directly via
such genes asCYR61 andOPN, or indirectly through the recruit-
ment of inflammatory cells. Therefore we assessed the vascu-
larity and necrosis of PDSC5 tumors injected with or without
Figure 3. Skin CAFs Enhance Tumor Growth and Angio-
genesis
(A) HPV CAFs enhance the growth of PDSC5 cells when coin-
jected intradermally (*p < 0.05). Tumors resulting from coinjection
of PDSC5 cells and NDFs had an intermediate phenotype but
were significantly different from tumors resultant from injecting
PDSC5 cells alone (**p < 0.05). Results are representative of three
independent experiments with two separate HPV-derived tumor
cell lines, PDSC5.2 and PDSC5.6. Each orthotopic experiment
was performed with a different batch of fibroblasts.
(B and C) In vivo ultrasound imaging of orthotopic tumors. Error
bars show mean ± SEM.
(B) Representative ultrasound images of tumors. Three mice from
each group were analyzed. Asterisk indicates necrotic region.
(C) Ultrasound imaging of tumor vasculature following intravenous
injection of nontargeted microbubbles. See also Movies S1–S3.
(D) Immunostaining of blood vessels with anti-Meca32 antibody.
The panels are representative of multiple fields of tumor sections
from at least seven tumors per group. Scale bar, 100 mM.
(E) Quantification of blood vessel density in PDSC5 tumors. Blood
vessels in five different fields of three different tumors were quan-
tified. Error bars show mean ± SD. *p = 0.0002; **p = 0.021;
#p = 0.0057. See also Figure S3.
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Cancer-Associated Fibroblasts mediate inflammationfibroblasts. Ultrasound live imaging showed that tumors injected
with CAFs were less necrotic than tumors injected without fibro-
blasts or with NDFs (Figure 3B). Furthermore, tumors injected
with CAFs were significantly more vascularized, as assessed by
both ultrasound imaging using contrast enhancedmicro-bubbles
to visualize tumor blood flow (Figure 3C and Movies S1–S3), and
by immunostaining for the endothelial cell marker Meca-32 (Fig-
ure 3D). When the number of blood vessels was quantified, the
blood vessel density in tumors injected with CAFs was found to
be significantly higher than in controls (Figure 3E), supporting
the idea that HPV CAFs are protumorigenic, at least in part
because of their ability to promote angiogenesis.
We next examined possible mechanisms by which fibroblasts
might facilitate tumor vascularization. Several of the proinflam-
matory genes upregulated in CAFs are known chemoattractants
for macrophages and neutrophils (e.g., CXCL1, CXCL2, and
CXCL5). Therefore, we suspected that macrophages, which
are known to support tumor angiogenesis (Condeelis and
Pollard, 2006), might be differentially recruited to PDSC5 tumors
injected with CAFs. Indeed, immunostaining for the macrophage
marker CD68 showed that tumors injected with CAFs were more
heavily infiltrated by macrophages than were controlsCancer Cell(Figure 4A). Furthermore, in vivo Matrigel plug bioas-
says for angiogenesis revealed that plugs injected
with CAFs were significantly more vascularized and
contained more macrophages than did plugs injected
with NDFs or without fibroblasts (Figures 4B and 4C).
Importantly, these results demonstrate that CAFs are
not only critical for the recruitment of inflammatory
cells into tumors and for enhancement of angiogen-
esis, but also that they can directly mediate these
effects in the absence of tumor cells.
NF-kB is Activated in HPV Skin Fibroblasts
Several of the inflammatory genes upregulated in HPV
CAFs are known targets of the NF-kB transcriptionfactor (COX-2, IL-6, CXCL1, CXCL2, and IL-1b). NF-kB is upre-
gulated in several inflammation-linked cancers (Karin and
Greten, 2005; Pikarsky et al., 2004); however, its activity has
been previously implicated in the cancer cells (Meylan et al.,
2009; Wu et al., 2009) or in tissue macrophages (Greten et al.,
2004). To assess NF-kB activity in HPV CAFs, we performed
immunostaining for the NF-kB subunit p65 (RelA). When active,
the NF-kB heterodimer (RelA-p50) translocates to the nucleus,
where it activates the transcription of its target genes (Karin
and Ben-Neriah, 2000; Pereira and Oakley, 2008). Nuclear p65
staining was detected in the stroma of HPV skin sections but
not in the skin of nontransgenic control mice (Figure 5A). To
confirm that p65 is indeed active in fibroblasts, we performed
immunostaining on cultured low-passage primary fibroblasts
and found nuclear p65 staining in HPV dysplasia-derived fibro-
blasts but not in dermal fibroblasts derived from control mice,
demonstrating that NF-kB signaling is activated in CAFs
(Figure 5B).
IKKb is the catalytic subunit of IKK and is essential for NF-kB
activation (Chen et al., 2003). To determine whether the tumor-
promoting activity of the fibroblasts was dependent on NF-kB,
we knocked down Ikkb in CAFs using shRNA (Figure 5C).17, 135–147, February 17, 2010 ª2010 Elsevier Inc. 139
Figure 4. CAFs Recruit Macrophages and
Stimulate Angiogenesis
(A) Immunostaining of macrophages in PDSC5
orthotopic tumors with an antibody to CD68.
Asterisk indicates necrosis. The panels are repre-
sentative of multiple fields of tumor sections from
seven to nine tumors per group.
(B) Staining of Matrigel plug sections with anti-
CD68 to reveal macrophages following inocula-
tion of Matrigel with or without admixed NDFs or
CAFs. Results shown are representative of three
independent experiments.
(C) Staining of blood vessels with anti-Meca32
antibody in adjacent sections of the sameMatrigel
plugs admixed or not with NDFs or CAFs. Panels
are representative of multiple fields from seven
or eight plugs per group. Scale bar, 100 mM.
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Cancer-Associated Fibroblasts mediate inflammationKnockdown of IKKb did not have an effect in vitro on CAF
survival (data not shown). IKKb-shRNA CAFs were then coin-
jected orthotopically with PDSC5 cells. Tumors coinjected with
shRNA IKKb fibroblasts grew significantly slower than did
tumors coinjected with control fibroblasts (Figure 5D). Further-
more, the tumors contained fewer infiltrating macrophages and
were significantly less vascularized than controls (Figures 5E
and 5F). These findings provide evidence that the inflammation
and tumor enhancement mediated by HPV CAFs is NF-kB
dependent.
Education of Normal Fibroblasts by Carcinoma Cells
Intriguingly, admixing normal skin fibroblasts with carcinoma
cells resulted in tumor growth that, although slower than that
of tumors mixed with CAFs, was significantly greater than that
of tumor cells alone. This observation suggested in vivo ‘‘educa-
tion’’ of NDFs by the tumor cells. To test this hypothesis, primary
skin fibroblasts from nontransgenic control mice were incubated
with PDSC5-conditioned medium. Indeed, the inflammatory
signature was largely induced (Figure 6A). Interestingly, CYR61
was not induced, suggesting that it is under distinct regulation.
Furthermore, FACS-purified fibroblasts from end stage ortho-
topic tumors coinjected with NDFs expressed proinflammatory
genes, even though these fibroblasts were originally negative
for the inflammatory gene signature (Figure 6B). These findings
provide evidence for the in vivo ‘‘education’’ of dermal fibro-
blasts by tumor cells, consistent with the ex vivo education of
dermal fibroblasts in culture.
Because the genes in our proinflammatory signature were
largely known to be regulated by NF-kB in other contexts, we
next asked whether IL-1b, a potent inducer of the NF-kB
signaling pathway, could elicit expression of the signature genes
in fibroblasts. Indeed, when NDFs were incubated with IL-1b,
there was a strong induction of the signature genes known to
be NF-kB targets (Figure 6C). To ascertain whether IL-1b could140 Cancer Cell 17, 135–147, February 17, 2010 ª2010 Elsevier Inc.be inducing expression of the inflamma-
tory signature in NDFs, we assessed the
effects of neutralizing IL-1b on NF-kB
target genes in the inflammatory signa-
ture. Indeed, induction of the known
NF-kB target genes in NDFs was in-hibited when a neutralizing antibody to IL-1b was added to
PDSC5 conditioned medium, suggesting that education of
NDFs by tumor cells is mediated by IL-1b (Figures 6D–6G).
Proinflammatory CAFs First Appear in Incipient
Neoplasia
We next asked whether the proinflammatory gene signature
identified in CAFs from dysplastic tissue was already induced
in stromal fibroblasts isolated from the earlier hyperplastic stage
of tumor progression. Fibroblasts were sorted from hyperplastic
skin lesions of 1-month-old HPV mice and were assessed for
expression of the proinflammatory gene signature. With the
exception of IL-1b, the proinflammatory gene signature was
evident in fibroblasts sorted from these hyperplastic lesions
(Figure 7A), suggesting that such activated fibroblasts may
play a prominent role in both initiating and driving tumor-
promoting inflammation in skin carcinogenesis. Thus, CAFs
with a proinflammatory signature are first induced in the earliest
incipient neoplasias and persist as neoplastic progression leads
to invasive cancer.
Our data implicate IL-1b as the factor inducing the inflamma-
tory gene signature in NDFs. We therefore investigated possible
cellular sources of IL-1b in the preneoplastic stages. FACS-
sorted cell populations from dysplastic skin tissue of 4- or
6-month-old HPV mice were analyzed by real-time PCR, with
similar results. We found that fibroblasts, macrophages, and
dysplastic epithelial cells all expressed IL-1bmRNA in dysplastic
tissue. The expression of IL-1b in dysplastic epithelial cells was
further upregulated at 6 months, compared with 4 months (Fig-
ure 7B). Interestingly, only CD45+ immune cells expressed
IL-1b at the earlier hyperplastic stage, suggesting that an
immune cell type is inducing the initial expression of the inflam-
matory signature in NDFs (Figure 7C). Notably, a previous
study had implicated signaling by B-lymphocytes in the recruit-
ment of the innate inflammatory cells that stimulate neoplastic
Figure 5. Tumor Enhancement by Skin CAFs is NF-kB Dependent
(A) Dysplastic or normal ear tissue sections from 3-month-old HPV or control
mice, respectively, were immunostained with anti-p65 antibody (Rhoda-
mine-X) for the NF-kB subunit p65. Nuclei are shown in blue with DAPI. Panels
are representative of multiple fields from four control and five HPV mice.
(B) Primary fibroblasts were derived from 4-month-old HPV mice or age-
matched controls and were stained with anti-p65 antibody (Rhodamine-X).
Panels are representative of two cultures.
(C) mRNA levels of IKKb in control or IKKb shRNA-infected HPV fibroblasts.
Data are representative of four experiments.
(D) Tumor growth of PDSC5 cancer cells coinoculated with HPV fibroblasts
infected with either control vector or IKKb shRNA (*p < 0.05). Results shown
are representative of three independent experiments. Error bars show
mean ± SEM.
Cancer Cell
Cancer-Associated Fibroblasts mediate inflammation
Cprogression (de Visser et al., 2005). Thus, in HPV16/RAG1/
mice, incipient neoplasias do not progress beyond the hyper-
plastic stage, as a result of the failure to recruit innate inflamma-
tory cells. To test the hypothesis that adaptive immune cells
might be required for activation of NF-kB signaling in the induc-
tion of NDF to CAF, we performed immunostaining for p65 in skin
tissue from HPV16/RAG1/ mice, compared with wild-type
HPV mice. Indeed, there was no nuclear p65 staining in
HPV16/RAG1/ skin tissue (Figure 7D). Furthermore, when we
audited expression of the inflammatory gene signature in
HPV16/RAG1/ fibroblasts, compared with that in HPV CAFs,
the NF-kB-regulated subset proved to be very low (Figure 7E).
Thus, hyperplasia-associated fibroblasts in HPV16/RAG1/
mice do not become proinflammatory, which likely contributes
to the lack of proangiogenic immune cell recruitment and malig-
nant progression in these mice. To further decipher the mecha-
nism by which fibroblasts become activated, we asked whether
Ig deposition by B cells, previously implicated as a regulator of
the tumor-promoting inflammatory response (de Visser et al.,
2005), is required for CAF activation. To that end, we analyzed
the expression of the inflammatory signature in CAFs derived
from HPV16/FcRg/mice. These mice exhibit the same pheno-
type as the HPV16/RAG1/ mice, in that they do not progress
beyond benign hyperplasias (Andreu et al., 2010). Fibroblasts
isolated from hyperplastic lesions in HPV16/FcRg/ mice
proved to express low levels of the NF-kB-regulated subset of
the proinflammatory gene signature (Figure 7F), much like in
Rag null mice, and in contradistinction to fibroblasts from hyper-
plasias (and later stages) in wild-type HPV transgenic mice.
Because FcRg is not expressed by skin fibroblasts (data not
shown), these results suggest that B cells signal to FcRg-ex-
pressing innate immune cells that in turn activate NDFs to
become proinflammatory CAFs. Thus, the NF-kB -dependent
proinflammatory program in CAFs is initially induced within
incipient neoplasias by resident immune cells that had been
stimulated by adaptive immune cells to express IL-1b.
DISCUSSION
In this study, we identify a proinflammatory gene signature
responsible for the tumor-promoting behavior of CAFs. We
show that CAFs mediate inflammation and angiogenesis by
recruiting macrophages and stimulating angiogenesis, thus
enhancing tumor growth in squamous cell carcinoma. Fibro-
blasts from hyperplastic, dysplastic, and neoplastic skin of
K14-HPV16 mice express a proinflammatory gene signature
that, in significant part, depends on NF-kB signaling. The induc-
tion of this inflammatory gene signature in fibroblasts at the
earliest discernable stage (hyperplasia) of multistep squamous
carcinogenesis suggests that fibroblasts play a crucial role in
generating the inflammatory microenvironment that promotes
malignant progression in this model. Furthermore, fibroblasts
isolated from mouse models of mammary and pancreatic
adenocarcinoma and from human skin and pancreatic tumors
expressed many of the genes present in the proinflammatory(E and F) CD68 and Meca32 staining in tumors from (D). Panels are represen-
tative of multiple fields of tumor sections from seven tumors. Scale bar,
100 mM.
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Figure 6. Education of Fibroblasts by
Carcinoma Cells
(A) Induction of the inflammatory signature in
NDFs incubated overnight with PDSC5-condi-
tioned medium. Control fibroblasts were incu-
bated in SFM. A representative experiment out
of three performed is shown.
(B) Gene expression analysis in fibroblasts iso-
lated from end-stage orthotopic tumors injected
with NDFs. Fibroblasts were sorted from a pool
of three tumors. Results are representative of at
least two experiments. Pound sign (#) indicates
undetectable/very low expression.
(C) Cultured NDFs were treated with 10 ng/ml
IL-1b for 1 or 6 hr. Data shown are mean ± SD of
two experiments performed in duplicate.
(D–G) NDFs were incubated overnight with
PDSC5 CM with or without anti-IL-1b neutralizing
antibody. Control fibroblasts were incubated in
SFM. Results are representative of two experi-
ments performed in duplicate.
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inflammation in multiple cancers and in human disease. Collec-
tively, our results demonstrate that CAFs can promote tumor
growth by orchestrating the recruitment of inflammatory cells
and stimulating tumor angiogenesis throughout carcinogenesis,
beginning with incipient neoplasias.
Although the involvement of innate and adaptive immune cells
in cancer-promoting inflammation is well established (Condeelis
and Pollard, 2006; de Visser et al., 2006; Whiteside, 2008), few
studies have implicated fibroblasts in this process. CAFs have
been shown to promote tumor growth by directly stimulating
tumor cell proliferation and by enhancing angiogenesis (Allinen
et al., 2004; Bhowmick et al., 2004a; Orimo et al., 2005). Fibro-
blasts are also key players in wound healing (Hinz et al., 2007;
Kisseleva and Brenner, 2008), mediating different aspects of
this complex process, including extracellular matrix remodeling
and generation of contractile forces. Furthermore, fibroblasts
have been implicated in the pathogenesis of chronic inflamma-
tory diseases, such as rheumatoid arthritis and chronic obstruc-
tive pulmonary disease (Baglole et al., 2008; Flavell et al., 2008;
Martey et al., 2004). It has also been suggested that fibroblasts
mediate the transition from acute to chronic inflammation by
inappropriately providing recruitment, survival, and retention
signals to infiltrating leukocytes, thus inhibiting the normal reso-
lution of inflammation (Buckley et al., 2001; Smith et al., 1997).
Previous studies have reported that fibroblasts are a source of
cytokines or chemokines or both in tumors (Gallagher et al.,
2005; Mueller et al., 2007; Silzle et al., 2003). These reports,
however, involved in vitro assays and were potentially suscep-
tible to alterations in gene expression caused by cell culture
conditions. Recently, laser capture microdissection revealed
CXCL12 and CXCL14 to be upregulated in stroma of prostate
and basal cell carcinomas (Augsten et al., 2009; Micke et al.,142 Cancer Cell 17, 135–147, February 17, 2010 ª2010 Elsevier Inc.2007). Notably, the microdissected
stroma also contained immune cells,
which were inseparable from the fibro-
blasts. Extending on these results, our
experimental methodology involvingpurification by flow cytometry enabled profiling of in vivo-derived
fibroblasts, unequivocally demonstrating that CAFs functionally
orchestrate the proangiogenic inflammatory response during
squamous carcinogenesis.
CAFs from other organ sites have been shown to directly
enhance tumor angiogenesis by either recruiting endothelial
progenitor cells via their secretion of SDF-1/CXCL12 (Orimo
et al., 2005) or secreting proangiogenic factors (Nyberg et al.,
2008; Pietras et al., 2008). Here, we show that skin CAFs
enhanced angiogenesis both in orthotopic squamous carcinoma
tumors and in an in vivo Matrigel plug bioassay lacking cancer
cells. The upregulation of the proangiogenic gene CYR61 in
HPV CAFs suggests that angiogenesis may be directly medi-
ated, at least in part, by these CAFs. However, recruited macro-
phages are demonstrably proangiogenic in the HPV16-driven
mouse models of skin and cervical cancers, through their secre-
tion of MMP-9 and its mobilization of VEGF (Coussens et al.,
2000; Giraudo et al., 2004). Thus, tumor angiogenesis may
be mediated directly by CAFs or indirectly by macrophages
recruited by the proinflammatory CAFs.
Whenothermousemodels of cancerwere examined,we found
that CAFs sorted fromcervical tumors did not express the inflam-
matory signature. This finding could be explained by tissue-
specific differences in fibroblast populations. Indeed, fibroblasts
derived from different anatomical locations have been shown in
genomewide expression studies to be quite heterogeneous (Kal-
luri and Zeisberg, 2006; Rinn et al., 2006). In contradistinction,
CAFs from two other tumor types known to have a strong desmo-
plastic response, mammary and PDAC tumors, similarly express
proinflammatory genes, as did CAFs isolated from human squa-
mous skin carcinoma and human PDAC, suggesting that fibro-
blast-mediated inflammation may be a common phenomenon,
operative in multiple tumor types in human and mouse.
Figure 7. Early Activation of NDFs in HPV, but Not in HPV16/RAG1/ or HPV16/FcRg/ Skin
(A) Fibroblasts were sorted from hyperplastic or normal ear tissue of 1-month-old HPV or control mice, respectively. Fibroblasts were sorted from a pool of tissue
from 15 age-matched mice. Results are representative of at least three independent experiments. Pound sign (#) indicates undetectable/very low expression.
(B) Fibroblasts, macrophages (CD68+, F4/80+) and epithelial cells (E-Cadherin+) were FACS-purified from 4- or 6-month-old HPV mice. Results shown are from
pools of tissue sorted from ten age-matched mice.
(C) Fibroblasts, immune cells (CD45+), and epithelial cells were similarly FACS-purified from skin tissue of 1-month-old HPVmice. Results shown are from pools of
tissue sorted from 14 age-matched mice.
(D) Ear tissue sections from 3-month-old HPV mice or from age-matched HPV16/RAG1/mice were immunostained with an anti-p65 antibody (Rhodamine-X)
for the NF-kB subunit p65. Arrow indicates positive nuclei. Nuclei are shown in blue with DAPI. Panels are representative of multiple fields of skin sections from
three HPV16/RAG1/ mice and four HPV mice. Scale bar, 100 mM.
(E and F) qRT-PCR for the inflammatory signature in fibroblasts derived from 4-month-old HPV and age-matched HPV16/RAG1/ mice (E) or from HPV16/
FcRg/ mice (F).
(G) A model for the role of CAFs in mediating tumor-promoting inflammation. Signaling interactions among cell types in the neoplastic microenvironments of the
stages in squamous skin carcinogenesis are shown, illustrating, in particular, the induction of CAFs and their functional role in amplifying the proangiogenic and
tumor-promoting inflammatory response.
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HPV CAFs is maintained in culture, implying a stable alteration.
Indeed, permanent changes in expression patterns have been
shown for synovial fibroblasts derived from patients with rheu-
matoid arthritis, compared with fibroblasts from noninflamed
joints (Buckley et al., 2001), and also in stromal fibroblasts and
stromal tissue associated with breast cancers (Finak et al.,
2008; Hu et al., 2005). We have shown that both induction and
maintenance of this proinflammatory signature are NF-kB
dependent. Thus, knock-down of NF-kB activity in HPV CAFs
by expression of an shRNA targeting IKKb abolished the
tumor-enhancing effect of HPV fibroblasts in orthotopic skin
tumors. NF-kB is known to play a central role in mediating protu-
morigenic inflammatory signaling, but its activity has previously
been ascribed to macrophages or cancer cells (Bollrath et al.,
2009; Grivennikov et al., 2009; Wu et al., 2009). Notably, the
NF-kB target genes COX-2, which is also in the gene signature
we identified, and IL-8 were both shown to be expressed in
human myofibroblasts in colorectal carcinoma tissue sections
(Adegboyega et al., 2004; Vandoros et al., 2006) and in cultured
CAFs from colorectal liver metastasis (Mueller et al., 2007), sug-
gesting that NF-kB signaling may also be operative in CAFs from
colorectal cancer. Our data expand and compliment these
observations and present functional evidence that activation
of NF-kB-dependent proinflammatory signaling is critical for
CAF-mediated tumor enhancement in vivo.
The in vivo ‘‘education’’ or ‘‘reprogramming’’ of normal fibro-
blasts by tumor cells demonstrated herein is relevant to the
origins of CAFs (Orimo andWeinberg, 2006). Epithelial tomesen-
chymal transition (EMT) is thought to be one of the sources of
CAFs in tumors (Kalluri and Weinberg, 2009). Although we
cannot formally exclude the possibility of EMT concomitant
with suppression of transgene expression, the possibility seems
unlikely, becausewe show that nontransgenic normal fibroblasts
can be educated to become inflammatory CAFs both in vitro and
in vivo. Indeed, we found that when normal fibroblasts were co-
injected with cancer cells and then isolated by flow cytometry
from the resultant orthotopic tumors, fibroblasts expressed the
characteristic proinflammatory CAF signature. It was previously
shown that coculturing of pancreatic or lung cancer cells with
stromal fibroblasts induced the expression of COX-2 and IL-8
(Anderson et al., 2000; Sato et al., 2004). The concept of
in vivo education of normal cells into tumor-promoting stromal
cells was previously ascribed to the recruitment of monocyte
progenitors and their differentiation into tumor-associated
macrophages, which are functionally distinct from resident
tissue macrophages (Pollard, 2004). Thus, cancer cells take
advantage of the plastic nature of reactive cell populations,
such as fibroblasts and macrophages, to generate a tumor-
enhancing microenvironment.
Although the cancer cells can demonstrably educate CAFs,
our findings suggest that dermal fibroblasts are first educated
by immune cells at the initial stages of tumorigenesis. CAFs
expressed the proinflammatory gene signature in the earliest
detectable incipient neoplasias, the hyperplastic stage in this
multistep pathway to squamous cell carcinomas. A variety of
stimuli could, in principle, elicit the early, premalignant expres-
sion of cytokines and chemokines in fibroblasts. We focused
on IL-1b, a known NF-kB activator (Ghosh and Karin, 2002),144 Cancer Cell 17, 135–147, February 17, 2010 ª2010 Elsevier Inc.which is expressed in skin CAFs but not NDFs, suspecting that
it might be the inducer of the NF-kB pathway. We found that
IL-1b is expressed exclusively by immune cells in early hyper-
plastic lesions, suggesting that activated resident immune cells
or sentry inflammatory cells initially induce normal fibroblasts
to become proinflammatory CAFs.
Thus, a complex heterotypic signaling network evidently
controls the induction, persistence, and dynamic variation of
the tumor microenvironment during squamous carcinogenesis
(Figure 7G). First, hyperplasia of the HPV16-expressing squa-
mous epithelia elicits B lymphocyte–dependent signaling to
innate immune cells to produce IL1-b, which then activate
normal fibroblasts to become CAFs. In turn, CAFs serve to
induce or amplify a tumor-promoting inflammatory response
by secreting proinflammatory cytokines, thereby recruiting
proangiogenicmacrophages. The involvement of B cells as initial
triggers of fibroblast activation was previously established by the
analysis HPV16/RAG1/ mice (which lack B cells) and HPV16/
FcRg/ mice (which are defective in B cell signaling via IgG),
both of which fail to progress beyond hyperplasias because of
the lack of innate immune cell inflammation (de Visser et al.,
2005; Andreu et al., 2010). We found that fibroblasts isolated
from hyperplasias in HPV16/RAG1/ and HPV16/FcRg/
mice did not express the NF-kB-regulated subset of the inflam-
matory gene signature, consistent with the postulate that the
impaired neoplastic progression of these mice results from the
inability to induce inflammatory signaling in CAFs, which in turn
fail to recruit proangiogenic macrophages that are instrumental
for tumor progression in this model.
Importantly, the signaling interactions evolve with neoplastic
progression. Thus, in contrast to the hyperplastic stage, where
only immune cells express IL-1b, other cell types in advanced
dysplasias and squamous carcinomas express IL-1b in addition
to immune cells, including CAFs and epithelial cells. As such,
IL-1b is both an inducer and a member of the CAF signature.
Notably, once NDFs are educated to become CAFs, the CAF
phenotype becomes meta-stable (evidenced by maintenance
in cell culture), likely facilitating malignant progression and
expansion. A recent study showed that hyperactivating PI3K
signaling inmammary CAFs results in tumor enhancement (Trim-
boli et al., 2009). Our results suggest that paracrine signaling by
IL-1b could be the physiological instigator of the PI3K-depen-
dent activation of stromal fibroblasts observed in this study,
because IL-1b has been shown in other contexts to activate
PI3K (Cahill and Rogers, 2008) as well as NF-kB. Interestingly,
IL-1b is evidently not only an initial inducer but also a downstream
effector of the CAF phenotype: IL-1b is upregulated in the
various mouse and human CAFs we have studied, as well as in
the mouse mammary CAFs studied by Trimboli et al. (2009).
Thus, both PI3K and NF-kB may be components of an intracel-
lular regulatory circuit that causes CAFs to become amplifiers
of the tumor-promoting inflammatory response.
In summary, we have demonstrated that dermal fibroblasts
are activated during early preneoplastic stages of tumorigenesis
to express and maintain a proinflammatory gene signature.
These proinflammatory CAFs mediate innate immune cell re-
cruitment and augment tumor angiogenesis, thereby enhancing
tumor growth, in an NF-kB-dependent manner. These results
further highlight the functional importance of CAFs and suggest
Cancer Cell
Cancer-Associated Fibroblasts mediate inflammationthat therapeutic targeting of CAF regulatory or effector circuits
(e.g., by inhibiting NFkB signaling) could be of value in treating
certain forms of human cancer.
EXPERIMENTAL PROCEDURES
Transgenic Mice and Human Samples
Generation and characterization of HPV16 and HPV16/RAG1/ mice have
been described elsewhere (Arbeit et al., 1994; Coussens et al., 1996; de Visser
et al., 2005). HPV16/FcRg/mice were provided by Lisa Coussens’s labora-
tory at University of California, San Francisco (UCSF) (Andreu et al., 2010). All
mice were maintained within the UCSF Laboratory for Animal Care barrier
facility, and all experiments involving animals were approved by the Institu-
tional Animal Care and Use Committee of UCSF. Human tissue was obtained
from the Surgery Department and Dermatologic Surgery and Laser Center at
UCSF. Written informed consent was obtained from each patient prior to
enrollment. The protocol and informed consent document was approved by
the UCSF Committee on Human Research (Institutional Review Board).
Orthotopic Tumors
PDSC5 cells (53 105) were injected intradermally into FVB/n mice alone or ad-
mixed with 1.5 3 106 early passage NDFs or HPV CAFs. To prepare IKKb
knockout fibroblasts, IKKb shRNA and control vector were purchased from
OpenBiosystems. Virus was prepared by the UCSF Lentiviral Core. HPV
CAFs were infected overnight with fresh, unconcentrated virus followed by
48 hr selection with Puromycin. Cells were resuspended in PBS and mixed
1:1 in volume with Growth Factor Reduced Matrigel (BD Biosciences) immedi-
ately prior to injection. Tumors were measured every 3–4 days with calipers,
and tumor volumes were calculated using the formula X2 3Y 3 0.52, where
X = smaller diameter and Y = larger diameter. Tumor growth was measured
until tumors reached a size of 20 mm in any diameter. Mice were then killed,
and tumors were embedded in OCT for histological analysis.
Statistical Analysis
Statistical analyses were done by Student’s t test. Statistical significance was
defined as p < 0.05.
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